Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Scanbio Denmark ApS
APS
Active
CVR 42107654
Kuttervej 4
Processing and preserving of fish, crustaceans and molluscs · NACE 1020
Est. 2021
5 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 16,4M
+47% vs 2023
EBITDA margin
23.9%
-34% vs 2023
Equity ratio
35.1%
Financial strength
Net profit 2024
DKK 2M
-50% vs 2023
EBITDA — year on year
DKK millions
0M
2M
4M
6M
8M
1M
2021
6M
+500%
2022
6M
0%
2023
4M
-33%
2024
Key figures
Annual report 2024
Revenue
DKK 16,4M
+47%
EBITDA
DKK 3,9M
-34%
Net profit
DKK 2M
-50%
Total assets
DKK 29,6M
+19%
Equity
DKK 10,4M
+24%
Employees
5
—
Company information
Legal name
Scanbio Denmark ApS
CVR number
42107654
Legal form
Anpartsselskab
NACE code
1020 · Processing and preserving of fish, crustaceans and molluscs
Founded
8. februar 2021
Share capital
DKK 40.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at drive virksomhed med handel, service, produktion og dermed forbundne aktiviteter.
Contact
Address
Kuttervej 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Processing and preserving of fish, crustaceans and molluscs
Companies in Bornholms Regionskommune
All Denmark companies
Revenue
DKK millions
0M
5M
9M
14M
18M
2M
2021
8M
2022
11M
2023
16M
2024
EBITDA
DKK millions
0M
2M
3M
5M
7M
1M
2021
6M
2022
6M
2023
4M
2024
Income statement
DKK thousands
Item
2021
2022
2023
2024
Revenue
2.485
8.062
11.151
16.399
Staff expenses
-1.404
-2.203
-5.253
-12.487
EBITDA
1.081
5.859
5.898
3.912
Depreciation & amort.
-277
-558
-524
-491
EBIT
804
5.301
5.374
3.421
Net financials
-230
-277
-216
-830
Profit before tax
574
5.025
5.158
2.591
Tax
126
1.140
1.144
591
Net profit
448
3.885
4.014
1.999
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
Total assets
20.544
28.500
24.908
29.560
Equity
488
4.372
8.386
10.385
Long-term debt
0
0
0
0
Short-term debt
19.931
23.669
15.959
18.566
Total debt
19.931
23.669
15.959
18.566
Financial ratios
5-year trend
EBITDA margin
23.9%
This company
15.8%
Market median
+51% vs market
2021
2024
Equity ratio
35.1%
This company
38.2%
Market median
+8% vs market
2021
2024
Return on equity
19.3%
This company
18.4%
Market median
+5% vs market
2021
2024
Net profit margin
12.2%
This company
8.1%
Market median
+51% vs market
2021
2024
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
2021
2024
Debt / equity
1.85×
This company
0.62×
Market median
-198% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-02-08 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
KH
Karsten Himmelstrup
Management
Management
2021
—
—
TV
Tor Vikenes
Management
Management
2025
—
—
KG
Kamel Gabriel El Khaloui
Management
Management
2021
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Scanbio Ingredients AS
Individual
100.0%
100.0%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Scanbio Denmark ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Karsten Himmelstrup
Management
0 companies
Tor Vikenes
Management
0 companies
Kamel Gabriel El Khaloui
Management
0 companies